Cargando…

Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific

BACKGROUND: Aedes mosquitoes severely affect the health and wellbeing of human populations by transmitting infectious diseases. In French Polynesia, Aedes aegypti is the main vector of dengue, chikungunya and Zika, and Aedes polynesiensis the primary vector of Bancroftian filariasis and a secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathieu-Daudé, Françoise, Claverie, Aurore, Plichart, Catherine, Boulanger, Denis, Mphande, Fingani A., Bossin, Hervé C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075770/
https://www.ncbi.nlm.nih.gov/pubmed/30040826
http://dx.doi.org/10.1371/journal.pntd.0006660
_version_ 1783344612796006400
author Mathieu-Daudé, Françoise
Claverie, Aurore
Plichart, Catherine
Boulanger, Denis
Mphande, Fingani A.
Bossin, Hervé C.
author_facet Mathieu-Daudé, Françoise
Claverie, Aurore
Plichart, Catherine
Boulanger, Denis
Mphande, Fingani A.
Bossin, Hervé C.
author_sort Mathieu-Daudé, Françoise
collection PubMed
description BACKGROUND: Aedes mosquitoes severely affect the health and wellbeing of human populations by transmitting infectious diseases. In French Polynesia, Aedes aegypti is the main vector of dengue, chikungunya and Zika, and Aedes polynesiensis the primary vector of Bancroftian filariasis and a secondary vector of arboviruses. Tools for assessing the risk of disease transmission or for measuring the efficacy of vector control programmes are scarce. A promising approach to quantify the human-vector contact relies on the detection and the quantification of antibodies directed against mosquito salivary proteins. METHODOLOGY/PRINCIPAL FINDINGS: An ELISA test was developed to detect and quantify the presence of immunoglobulin G (IgG) directed against proteins from salivary gland extracts (SGE) of Ae. aegypti and Ae. polynesiensis in human populations exposed to either species, through a cross-sectional study. In Tahiti and Moorea islands where Ae. aegypti and Ae. polynesiensis are present, the test revealed that 98% and 68% of individuals have developed IgG directed against Ae. aegypti and Ae. polynesiensis SGE, respectively. By comparison, ELISA tests conducted on a cohort of people from metropolitan France, not exposed to these Aedes mosquitoes, indicated that 97% of individuals had no IgG directed against SGE of either mosquito species. The analysis of additional cohorts representing different entomological Aedes contexts showed no ELISA IgG cross-reactivity between Ae. aegypti and Ae. polynesiensis SGE. CONCLUSIONS/SIGNIFICANCE: The IgG response to salivary gland extracts seems to be a valid and specific biomarker of human exposure to the bites of Ae. aegypti and Ae. polynesiensis. This new immuno-epidemiological tool will enhance our understanding of people exposure to mosquito bites, facilitate the identification of areas where disease transmission risk is high and permit to evaluate the efficacy of novel vector control strategies in Pacific islands and other tropical settings.
format Online
Article
Text
id pubmed-6075770
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60757702018-08-28 Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific Mathieu-Daudé, Françoise Claverie, Aurore Plichart, Catherine Boulanger, Denis Mphande, Fingani A. Bossin, Hervé C. PLoS Negl Trop Dis Research Article BACKGROUND: Aedes mosquitoes severely affect the health and wellbeing of human populations by transmitting infectious diseases. In French Polynesia, Aedes aegypti is the main vector of dengue, chikungunya and Zika, and Aedes polynesiensis the primary vector of Bancroftian filariasis and a secondary vector of arboviruses. Tools for assessing the risk of disease transmission or for measuring the efficacy of vector control programmes are scarce. A promising approach to quantify the human-vector contact relies on the detection and the quantification of antibodies directed against mosquito salivary proteins. METHODOLOGY/PRINCIPAL FINDINGS: An ELISA test was developed to detect and quantify the presence of immunoglobulin G (IgG) directed against proteins from salivary gland extracts (SGE) of Ae. aegypti and Ae. polynesiensis in human populations exposed to either species, through a cross-sectional study. In Tahiti and Moorea islands where Ae. aegypti and Ae. polynesiensis are present, the test revealed that 98% and 68% of individuals have developed IgG directed against Ae. aegypti and Ae. polynesiensis SGE, respectively. By comparison, ELISA tests conducted on a cohort of people from metropolitan France, not exposed to these Aedes mosquitoes, indicated that 97% of individuals had no IgG directed against SGE of either mosquito species. The analysis of additional cohorts representing different entomological Aedes contexts showed no ELISA IgG cross-reactivity between Ae. aegypti and Ae. polynesiensis SGE. CONCLUSIONS/SIGNIFICANCE: The IgG response to salivary gland extracts seems to be a valid and specific biomarker of human exposure to the bites of Ae. aegypti and Ae. polynesiensis. This new immuno-epidemiological tool will enhance our understanding of people exposure to mosquito bites, facilitate the identification of areas where disease transmission risk is high and permit to evaluate the efficacy of novel vector control strategies in Pacific islands and other tropical settings. Public Library of Science 2018-07-24 /pmc/articles/PMC6075770/ /pubmed/30040826 http://dx.doi.org/10.1371/journal.pntd.0006660 Text en © 2018 Mathieu-Daudé et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mathieu-Daudé, Françoise
Claverie, Aurore
Plichart, Catherine
Boulanger, Denis
Mphande, Fingani A.
Bossin, Hervé C.
Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific
title Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific
title_full Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific
title_fullStr Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific
title_full_unstemmed Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific
title_short Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific
title_sort specific human antibody responses to aedes aegypti and aedes polynesiensis saliva: a new epidemiological tool to assess human exposure to disease vectors in the pacific
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075770/
https://www.ncbi.nlm.nih.gov/pubmed/30040826
http://dx.doi.org/10.1371/journal.pntd.0006660
work_keys_str_mv AT mathieudaudefrancoise specifichumanantibodyresponsestoaedesaegyptiandaedespolynesiensissalivaanewepidemiologicaltooltoassesshumanexposuretodiseasevectorsinthepacific
AT claverieaurore specifichumanantibodyresponsestoaedesaegyptiandaedespolynesiensissalivaanewepidemiologicaltooltoassesshumanexposuretodiseasevectorsinthepacific
AT plichartcatherine specifichumanantibodyresponsestoaedesaegyptiandaedespolynesiensissalivaanewepidemiologicaltooltoassesshumanexposuretodiseasevectorsinthepacific
AT boulangerdenis specifichumanantibodyresponsestoaedesaegyptiandaedespolynesiensissalivaanewepidemiologicaltooltoassesshumanexposuretodiseasevectorsinthepacific
AT mphandefingania specifichumanantibodyresponsestoaedesaegyptiandaedespolynesiensissalivaanewepidemiologicaltooltoassesshumanexposuretodiseasevectorsinthepacific
AT bossinhervec specifichumanantibodyresponsestoaedesaegyptiandaedespolynesiensissalivaanewepidemiologicaltooltoassesshumanexposuretodiseasevectorsinthepacific